SE0100901D0 - New composition - Google Patents

New composition

Info

Publication number
SE0100901D0
SE0100901D0 SE0100901A SE0100901A SE0100901D0 SE 0100901 D0 SE0100901 D0 SE 0100901D0 SE 0100901 A SE0100901 A SE 0100901A SE 0100901 A SE0100901 A SE 0100901A SE 0100901 D0 SE0100901 D0 SE 0100901D0
Authority
SE
Sweden
Prior art keywords
new composition
composition
lipoglobules
inflammation
pain
Prior art date
Application number
SE0100901A
Other languages
English (en)
Swedish (sv)
Inventor
Britta Siekmann
Barbro Thoring
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0100901A priority Critical patent/SE0100901D0/xx
Publication of SE0100901D0 publication Critical patent/SE0100901D0/xx
Priority to CNA028065271A priority patent/CN1496253A/zh
Priority to JP2002572990A priority patent/JP2004523577A/ja
Priority to KR10-2003-7011860A priority patent/KR20030082971A/ko
Priority to CA002435825A priority patent/CA2435825A1/en
Priority to EP02704035A priority patent/EP1370239A1/en
Priority to US10/471,378 priority patent/US20040096494A1/en
Priority to MXPA03007093A priority patent/MXPA03007093A/es
Priority to IL15681802A priority patent/IL156818A0/xx
Priority to BR0207760-4A priority patent/BR0207760A/pt
Priority to PCT/SE2002/000476 priority patent/WO2002074282A1/en
Priority to ZA200306282A priority patent/ZA200306282B/en
Priority to NO20034026A priority patent/NO20034026L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0100901A 2001-03-15 2001-03-15 New composition SE0100901D0 (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE0100901A SE0100901D0 (sv) 2001-03-15 2001-03-15 New composition
PCT/SE2002/000476 WO2002074282A1 (en) 2001-03-15 2002-03-13 New composition
CA002435825A CA2435825A1 (en) 2001-03-15 2002-03-13 New composition
JP2002572990A JP2004523577A (ja) 2001-03-15 2002-03-13 新規組成物
KR10-2003-7011860A KR20030082971A (ko) 2001-03-15 2002-03-13 신규 조성물
CNA028065271A CN1496253A (zh) 2001-03-15 2002-03-13 新组合物
EP02704035A EP1370239A1 (en) 2001-03-15 2002-03-13 New composition
US10/471,378 US20040096494A1 (en) 2001-03-15 2002-03-13 Composition
MXPA03007093A MXPA03007093A (es) 2001-03-15 2002-03-13 Nueva composicion.
IL15681802A IL156818A0 (en) 2001-03-15 2002-03-13 New composition
BR0207760-4A BR0207760A (pt) 2001-03-15 2002-03-13 Composição farmacêutica, uso da mesma, métodos para o tratamento de dor e de inflamação, e, processo para a preparação de uma composição
ZA200306282A ZA200306282B (en) 2001-03-15 2003-08-13 New composition.
NO20034026A NO20034026L (no) 2001-03-15 2003-09-11 Nytt preparat

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0100901A SE0100901D0 (sv) 2001-03-15 2001-03-15 New composition

Publications (1)

Publication Number Publication Date
SE0100901D0 true SE0100901D0 (sv) 2001-03-15

Family

ID=20283373

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0100901A SE0100901D0 (sv) 2001-03-15 2001-03-15 New composition

Country Status (13)

Country Link
US (1) US20040096494A1 (zh)
EP (1) EP1370239A1 (zh)
JP (1) JP2004523577A (zh)
KR (1) KR20030082971A (zh)
CN (1) CN1496253A (zh)
BR (1) BR0207760A (zh)
CA (1) CA2435825A1 (zh)
IL (1) IL156818A0 (zh)
MX (1) MXPA03007093A (zh)
NO (1) NO20034026L (zh)
SE (1) SE0100901D0 (zh)
WO (1) WO2002074282A1 (zh)
ZA (1) ZA200306282B (zh)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
MXPA04002446A (es) 2001-09-26 2004-07-23 Baxter Int Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente.
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
GB0207529D0 (en) 2002-04-02 2002-05-08 Norbrook Lab Ltd Injectable veterinary composition for small animals
US20040018237A1 (en) * 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
US7163958B2 (en) * 2002-07-03 2007-01-16 Nitromed Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
ATE521355T1 (de) * 2004-05-19 2011-09-15 Los Angeles Biomed Res Inst Verwendung eines detergens zur nicht- chirurgischen entfernung von fett
US20060127468A1 (en) * 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
EP1886667A1 (en) * 2006-08-08 2008-02-13 The Jordanian Pharmaceutical Manufacturing Co. Ltd. Microemulsified drug formulation
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
CA2827643C (en) 2011-02-18 2019-05-07 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
CN103547258B (zh) * 2011-03-17 2017-10-20 特兰斯德梅尔生物工艺股份有限公司 局部一氧化氮系统及其使用方法
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871259B2 (en) * 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871255B2 (en) * 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US20140271938A1 (en) * 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9295637B2 (en) * 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9849160B2 (en) * 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9339457B2 (en) * 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9393264B2 (en) * 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9314422B2 (en) * 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US20140271731A1 (en) * 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9314417B2 (en) * 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US20140271937A1 (en) * 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9314423B2 (en) * 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9320706B2 (en) * 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9393265B2 (en) * 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
MX2019009894A (es) * 2017-02-21 2019-10-09 Dsm Ip Assets Bv Uso de una composición alimenticia para reducir la emisión de metano en ruminantes, y para mejorar el rendimiento de los mismos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
SE9704833D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New formulation

Also Published As

Publication number Publication date
ZA200306282B (en) 2004-11-23
JP2004523577A (ja) 2004-08-05
NO20034026D0 (no) 2003-09-11
US20040096494A1 (en) 2004-05-20
WO2002074282A1 (en) 2002-09-26
IL156818A0 (en) 2004-02-08
KR20030082971A (ko) 2003-10-23
CA2435825A1 (en) 2002-09-26
EP1370239A1 (en) 2003-12-17
NO20034026L (no) 2003-11-11
MXPA03007093A (es) 2003-11-18
BR0207760A (pt) 2004-06-01
CN1496253A (zh) 2004-05-12

Similar Documents

Publication Publication Date Title
SE0100901D0 (sv) New composition
EE05419B1 (et) Asendatud oksasolidinoonid kombineeritud raviks
ATE289640T1 (de) Amidofunktionelle aminopolydiorganosiloxane
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
IS6957A (is) Tatrat sölt af 5,8,14,-tríasatetrasýkló[10.3.1.02,11.04,9]-hexadeka-2(11),3,5,7,9,-pentaen og lyfjafræðilegar samsetningar af þeim
BR0317715A (pt) Composições e processos de uso de collajolie
TR200202194T2 (tr) Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri
DK0703786T3 (da) Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
WO2002011764A3 (en) PHARMACEUTICAL COMPOSITIONS
ATE340844T1 (de) Stabile, wässerige zusammensetzungen zur behandlung von oberflächen , insbesondere geweben
BR0215405A (pt) Composições e processos de uso de collajolie
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
DE60142913D1 (de) Arzneilösungen enthaltend modafinilverbindungen
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
ATE256392T1 (de) Verwendung von polyaminosäurederivate als konservierungsmittel
NO20040702L (no) Kombinerte preparater som inneholder 1,4-benzotiepin-1,1-dioksidderivater og andre aktive substanser og anvendelsen derav
SE0001916D0 (sv) Novel formulation
BR0313230A (pt) Uso de carboxamidas para o tratamento de tinido
SE0000303D0 (sv) Novel compounds
ATE241640T1 (de) Fusidinsäure-derivate
SE0300535D0 (sv) Treatment of burns
AU2001274138A1 (en) Propanolaminotetralines, preparation thereof and compositions containing same
ATE402178T1 (de) Substituierte 5,6,6a,11b-tetrahydro-7-oxa-5-aza- benzoäcüfluoren-6-carbonsäurederivate als nmda- antagonisten
KR970019821A (ko) 송진을 함유한 치약 제조 방법